Frontlight ResearchEarly access
Trial site
Sagamihara
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Childhood cancers2 trials
- Multiple sclerosis2 trials
- Polymyalgia rheumatica2 trials
- Stroke2 trials
- Chronic myeloid leukaemia1 trial
- Giant cell arteritis1 trial
- Huntington's disease1 trial
- Lung cancer1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Huntington's disease1 recruiting
Closed trials
Recruiting
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026